Cad is brí le “Soiléir”?
Ní iompraíonn an t-ainmhí an sóchán. Ní dhéanfaidh sé an galar a fhorbairt agus ní chuirfidh sé ar aghaidh é.
Discover the importance of DNA testing for Canine Leukocyte Adhesion Deficiency (CLAD) in dogs. CLAD is a serious genetic disorder affecting the immune system, making dogs more susceptible to infections. Early detection through a simple DNA test can help pet owners make informed breeding decisions and ensure healthier puppies. Understanding CLAD allows for better management of affected dogs, improving their quality of life. This test is crucial for breeds prone to this condition, such as Irish Setters. Protect your furry friend with proactive measures by opting for a CLAD DNA test today. Invest in your dog’s health and well-being—knowledge is power!
Canine Leukocyte Adhesion Deficiency (CLAD) is a genetic disorder that affects the immune system of dogs, particularly prevalent in certain breeds like the Irish Setter. This condition impairs the ability of white blood cells to adhere to blood vessel walls, leading to increased susceptibility to infections. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions to reduce the incidence of CLAD in future generations. Early detection through testing is crucial for managing the health of affected dogs. Responsible breeding practices can help eliminate this debilitating condition from the gene pool.
Tá an tástáil DNA seo san áireamh ag tosú ónár bpacáiste Basic — agus tá sé mar chuid de na pacáistí freisin Basic, Standard, Advanced, Complete.
Féach ar Pacáistí Tástála DNA →Canine Leukocyte Adhesion Deficiency (CLAD) is a genetic disorder primarily affecting the immune system of dogs. It is caused by a mutation in a specific gene that is responsible for the development and function of leukocytes, or white blood cells. This condition leads to an inability of leukocytes to adhere to blood vessel walls, which is crucial for their migration to sites of infection or inflammation.
Dogs affected by CLAD typically exhibit a range of clinical signs due to their compromised immune response. Common symptoms include recurrent infections, poor wound healing, and chronic inflammation. Affected dogs may also show signs of systemic illness, such as fever, lethargy, and weight loss. The severity of these symptoms can vary widely among individuals, depending on the extent of their immune dysfunction.
The diagnosis of CLAD is primarily achieved through genetic testing. A DNA test specifically designed to identify the mutation associated with CLAD can confirm the diagnosis. This test is crucial for breeders and dog owners to understand the genetic status of their dogs and to make informed breeding decisions. Early detection can also help in managing the health of affected dogs more effectively.
Currently, there is no cure for CLAD; however, management strategies can be employed to improve the quality of life for affected dogs. Treatment often involves prompt and aggressive management of infections with antibiotics and supportive care. Additionally, owners may need to take extra precautions to minimize exposure to pathogens, such as avoiding dog parks or other areas where dogs congregate.
Genetic testing for CLAD is vital for responsible breeding practices. By identifying carriers and affected individuals, breeders can make informed decisions to avoid producing affected puppies. This not only helps in reducing the prevalence of the condition in the population but also promotes overall canine health and welfare.
Canine Leukocyte Adhesion Deficiency is a serious genetic condition that poses significant health challenges for affected dogs. Understanding this disorder, recognizing its symptoms, and utilizing genetic testing are essential steps in managing the condition and ensuring the health of future generations of dogs. By prioritizing genetic health, dog owners and breeders can contribute to a healthier canine population.
Ní iompraíonn an t-ainmhí an sóchán. Ní dhéanfaidh sé an galar a fhorbairt agus ní chuirfidh sé ar aghaidh é.
Tá an t-ainmhí sláintiúil go ginearálta ach is féidir leis an sóchán a tharchur chuig a sliocht.
Tá dhá chóip mutated ar iompar aige. Táthar ag súil le comharthaí cliniciúla ag brath ar an galar. Níor chóir é a phóraítear.
Tá roinnt galair ceangailte le gnéas, mar sin athraíonn a léiriú ag brath ar an gnéas ainmhí.
This DNA test detects the mutation associated with Canine Leukocyte Adhesion Deficiency (CLAD) in order to identify clear, carrier, or at-risk animals.
Cuidíonn tástáil DNA le póraitheoirí cúplála níos sábháilte a phleanáil agus an baol go dtarchuirfear an sóchán chuig an sliocht a laghdú.
Is é Autosomal Recessive an modh oidhreachta a thuairiscítear don tástáil seo.
This test analyses the mutation ITGB2 c.107G>C.
Ní gá. Braitheann an léirmhíniú ar an bpatrún oidhreachta agus ar an géinitíopa dá bharr.
Kijas J M, Bauer T R Jr, Gäfvert S, Marklund S, TrowaldWigh G, Johannisson A, Hedhammar A, Binns M, Juneja R K, Hickstein D D, Andersson L. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics. 1999 Oct 1;61(1):101-7. doi: 10.1006/geno.1999.5948.
Do phríobháideachas, do rogha
Bainimid úsáid as fianáin riachtanacha chun an suíomh Gréasáin a rith. Díchumasaítear fianáin roghnacha (cosúil le soláthraithe ábhair leabaithe) de réir réamhshocraithe agus ní chuirtear ar chumas iad ach amháin má aontaíonn tú. Is féidir leat do rogha a athrú am ar bith agus an cnaipe “Fianáin” á úsáid agat.
Ag teastáil le haghaidh gnéithe lárnacha agus slándála. Cumasaithe i gcónaí.
Feabhsaítear gnéithe mar shábháil tosaíochta nó leabaithe neamhfhógraíochta.
Cuidíonn sé linn úsáid láithreáin a thuiscint. Díchumasaithe de réir réamhshocraithe.
Fógraíocht/rianú trasna suíomhanna (leabaíonn roinnt fístéipeanna/léarscáileanna). Díchumasaithe de réir réamhshocraithe.